“The world is in desperate need of safer therapies for pain and inflammation,” Dr Stauffer said. “Antibe represents one of the few truly novel platforms in the field, and I look forward to playing a role in navigating its drug pipeline through the later stages of clinical development, and ultimately providing patients with a safer treatment paradigm for pain management.”
In connection with Dr Stauffer’s appointment, the company has granted him a total of 500,000 restricted share units (RSUs). All RSUs are subject to time-based vesting; one-third of the RSUs granted will vest on each of the first, second and third anniversaries of today’s date.)
Duster340 writes: lets say the stock price was @ $4.00 on may/6th/2021 stauffer got 1/3 of 500k which is 166.66k x 4 = 666.64 thousand not bad. even at $1.50 per share he would have made a cool 250 thousand all these guys are getting paid huge money regardless of how the stock performs. how did you guys make out. it,s a scam they have a drug that is not what they pump it up to be, all they have to do is drag it out as many years as possible and they get rich off of the rsu's. they are not alone how many other companies do you know of that where hyped, and then crashed and burned, the old pump and dump, totaly legal though, the rich get richer while share holders pay the price. i feel sorry for you guys. i hope this is not the case here but will only be known in time.
glta